GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Veterinary Medical Association (AVMA)  (2)
  • Venta, Patrick J.  (2)
  • Unknown  (2)
Material
Publisher
  • American Veterinary Medical Association (AVMA)  (2)
Language
  • Unknown  (2)
Years
  • 1
    In: American Journal of Veterinary Research, American Veterinary Medical Association (AVMA), Vol. 63, No. 7 ( 2002-07-01), p. 987-993
    Abstract: Objective —To determine the effects of prostaglandin E 2 (PGE 2 ) on recombinant equine interleukin (IL)-1β-stimulated expression of matrix metalloproteinases (MMP 1, MMP 3, MMP 13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP 1) in vitro. Sample Population —Cultured equine chondrocytes. Procedure —Stationary monolayers of first-passage chondrocytes were exposed to graduated concentrations of PGE 2 with or without a subsaturating dose (50 pg/ml) of recombinant equine IL-1β (reIL-1β) to induce expression of MMP 1, MMP 3, MMP 13, and TIMP 1, followed by RNA isolation and northern blotting. In subsequent experiments, gene expression was similarly quantified from mRNA isolated from cultures pretreated with phenylbutazone to quench endogenous PGE 2 synthesis, followed by exposure to reIL-1β and exogenous PGE 2 (5 mg/ml) with appropriate controls. Results —Exogenous PGE 2 (10 mg/ml) significantly reduced reIL-1β-induced expression of MMP 1, MMP 3, MMP 13, and TIMP 1. Abrogation of cytokine induction with this dose of PGE 2 was comparable to that for dexamethasone (10 –5 M ) control. Similarly, pretreatment with phenylbutazone, followed by exposure to reIL-1β and PGE 2 (5 mg/ml), was associated with a reduced expression of the genes of interest, an effect that was significant for MMP 1, MMP 13, and TIMP 1. Conclusions and Clinical Relevance —The MMP and TIMP 1 are important mediators in the pathophysiologic events in osteoarthritis. The potential for physiologically relevant regulation of expression of these genes by PGE 2 is a consideration in the use of drugs that inhibit prostanoid synthesis in the treatment of equine arthropathies. ( Am J Vet Res 2002;63:987–993)
    Type of Medium: Online Resource
    ISSN: 0002-9645
    Language: Unknown
    Publisher: American Veterinary Medical Association (AVMA)
    Publication Date: 2002
    detail.hit.zdb_id: 2056942-7
    SSG: 22
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    American Veterinary Medical Association (AVMA) ; 2002
    In:  American Journal of Veterinary Research Vol. 63, No. 8 ( 2002-08-01), p. 1134-1139
    In: American Journal of Veterinary Research, American Veterinary Medical Association (AVMA), Vol. 63, No. 8 ( 2002-08-01), p. 1134-1139
    Abstract: Objective —To determine the effects of recombinant equine interleukin -1β (reIL-1β) and 4 anti-inflammatory compounds on the expression and activity of cyclooxygenase (COX)-2 in cultured equine chondrocytes. Sample Population —Articular cartilage from 9 young adult horses. Procedure —Reverse transcriptase-polymerase chain reaction methods were used to amplify a portion of equine COX-2 to prepare a cDNA probe. Northern blot analysis was used to quantify the expression of COX-2 in first-passage cultures of equine articular chondrocytes propagated in media containing dexamethasone (DEX), phenylbutazone (PBZ), polysulfated glycosaminoglycan, and hyaluronan, each at concentrations of 10 and 100 µg/ml and each with or without reIL-1β. A commercial immunoassay was used to determine prostaglandin E 2 (PGE 2 ) concentrations in conditioned medium of similarly treated cells to quantify COX-2 activity. Results —Addition of reIL-1β increased the expression of COX-2 in a dose-dependent manner, which was paralleled by an increased concentration of PGE 2 in culture medium. Concentration of PGE 2 in spent medium from reIL-1β-treated chondrocytes was significantly reduced by DEX and PBZ; however, only DEX significantly reduced gene expression of COX-2. Conclusions and Clinical Relevance —Prostaglandin E 2 is considered to be an important mediator in the pathophysiologic processes of arthritis, and cultured chondrocytes respond to interleukin-1 with enhanced expression and activity of COX-2. Palliative relief in affected horses is probably attributable, in part, to inhibition of PGE 2 synthesis; however, analysis of these data suggests that of the 4 compounds tested, only DEX affects pretranslational regulation of the COX-2 gene in cultured equine chondrocytes. ( Am J Vet Res 2002;63:1134–1139)
    Type of Medium: Online Resource
    ISSN: 0002-9645
    Language: Unknown
    Publisher: American Veterinary Medical Association (AVMA)
    Publication Date: 2002
    detail.hit.zdb_id: 2056942-7
    SSG: 22
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...